|
|
||||||||
The Annals of Thoracic Surgery, Vol 54, 1144-1150, Copyright © 1992 by The Society of Thoracic Surgeons
JM Pearl, H Laks, DC Drinkwater, A Meneshian, SM Martin, M Curzan and PA Chang
Blood cardioplegia is considered by many to be the preferred solution for
myocardial protection. Proposed benefits include the ability to deliver
oxygen and the ability to maintain metabolic substrate stores. However, the
decreased capacity of blood to release oxygen at hypothermic conditions as
well as the presence of deleterious leukocytes, platelets, and complement
may limit complete functional recovery. Fluosol is an asanguineous solution
with the ability to bind and release oxygen linearly at low temperatures.
Neonatal piglet hearts (24 to 48 hours old) were excised and supported on
an isolated, blood- perfused working heart model. After baseline
stroke-work index was determined, hearts were arrested with either
normocalcemic blood cardioplegia (group 1, n = 8) or normocalcemic Fluosol
cardioplegia (group 2, n = 8). Cold cardioplegia was administered at 45 mm
Hg every 20 minutes for 2 hours. Hearts were then reperfused with whole
blood. Functional recovery, expressed as percent of control stroke-work
index, was determined 60 minutes after reperfusion at left atrial pressures
of 3, 6, 9, and 12 mm Hg. Functional recovery at 60 minutes was similar
between group 1 (95%, 93%, 93%, 88%) and group 2 (100%, 94%, 94%, 95%) at
left atrial pressures of 3, 6, 9, and 12 mm Hg, respectively. Mean lactate
consumption 5 minutes after reperfusion was significantly greater (p =
0.0001) in group 1 (31.8 +/- 6.3 micrograms.min-1 x g-1) than in group 2
(-0.59 +/- 0.1 microgram.min-1 x g-1), indicating superior metabolic
recovery in the blood cardioplegia hearts. Edema formation, as determined
both by water content (group 1, 81.10%; group 2, 81.63%) and by electron
microscopy, was not significantly different between groups.(ABSTRACT
TRUNCATED AT 250 WORDS)
ARTICLES
Fluosol cardioplegia results in complete functional recovery: a comparison with blood cardioplegia
Department of Surgery, University of California, Los Angeles.
This article has been cited by other articles:
![]() |
J. N. Bhayana, Z. T. Tan, J. Bergsland, D. Balu, J. K. Singh, and E. L. Hoover Beneficial Effects of Fluosol-Polyethylene Glycol Cardioplegia on Cold, Preserved Rabbit Heart Ann. Thorac. Surg., February 1, 1997; 63(2): 459 - 464. [Abstract] [Full Text] |
||||
![]() |
A. Marchbank Fluorocarbon emulsions Perfusion, March 1, 1995; 10(2): 67 - 88. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |